MRI in PROstate Cancer Diagnosis With Prior Risk Assessment

NCT03225222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2558

Last updated 2023-09-07

No results posted yet for this study

Summary

To evaluate the diagnostic performance and cost-effectiveness of the MRI-driven diagnostic pathway of prostate cancer, with upfront individual multivariate risk stratification.

Conditions

Interventions

DIAGNOSTIC_TEST

biopsy

prostate biopsy

Sponsors & Collaborators

Principal Investigators

  • Ivo Schoots, Dr · Erasmus Medical Center

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03225222 on ClinicalTrials.gov